Theoretically, any biomolecule capable of interacting with specific metabolic or signaling pathways, such as lipids, carbohydrates, proteins, and nucleic acids, has the potential to be considered as a potential therapeutic target for treating a disease or disease. However, due to their own properties, these active substances require a suitable delivery system under natural physiological conditions to allow them to work in the correct place in the body. In order to extensively support the delivery research of active substances in vivo, CD BioSciences provides in vivo delivery systems customized according to the different cargoes contained, which can help you solve:

• Targeted Delivery: Ensuring that the active substances reach the specific cells or tissues where they are needed is essential for minimizing side effects and maximizing therapeutic efficacy. CD BioSciences' in vivo delivery systems are designed to precisely target the desired sites, reducing off-target effects and increasing treatment efficiency.
• Stability and Bioavailability: Many active substances, especially those of biological origin, can be fragile and prone to degradation in the body. Our delivery systems are engineered to protect these substances from degradation, thereby enhancing their stability and bioavailability, which is crucial for effective treatment.
• Controlled Release: Achieving the right release kinetics is often crucial for therapeutic success. CD BioSciences offers delivery systems that can provide controlled release of active substances over extended periods, ensuring a sustained therapeutic effect and minimizing the need for frequent dosing.
• Biocompatibility: The safety and compatibility of the delivery system with the body's natural processes are paramount. Our delivery systems are carefully designed to be biocompatible, minimizing the risk of adverse reactions or immune responses.
• Customization: We understand that different therapeutic agents have unique requirements. CD BioSciences collaborates closely with researchers and pharmaceutical companies to tailor our delivery systems to the specific characteristics of the cargo molecules, whether they are lipids, carbohydrates, proteins, or nucleic acids. This ensures that the delivery system is optimized for each application.
• Regulatory Compliance: Developing therapies involves navigating complex regulatory pathways. CD BioSciences is experienced in the regulatory requirements for in vivo delivery systems and can provide support in meeting these standards, helping to streamline the path to clinical trials and commercialization.
• Scalability: We recognize the importance of scalability in the development of therapeutic delivery systems. Our solutions are designed to be scalable for pre-clinical testing through to large-scale production, facilitating a smooth transition from research to clinical applications.
• Innovative Technologies: CD BioSciences stays at the forefront of scientific advancements in drug delivery. We continuously explore and incorporate cutting-edge technologies and materials into our delivery systems, ensuring that our clients have access to the latest tools for their research and therapeutic development efforts.

Figure 1. Schematization of nanoparticle-based gene therapy in vivo. (Chen J, et al.; 2016)

Key Features

• In vivo Antibody Delivery Services
• In vivo Nucleic Acid Delivery Services
• In vivo Small Molecule Drugs Delivery Services
• In vivo Peptide Delivery Services
• In vivo Polysaccharidee Delivery Services
• In vivo Functional Protein Delivery Services

Our Advantage:

• CD BioSciences can provide professional in vivo delivery systems for multiple active substances to achieve efficient in vivo delivery;
• Our delivery systems can add rich ligand modifications for targeting;
• The in vivo delivery system has low toxicity to the body and is safe to use In vivo antibody delivery system
• Carriers protect active substances from dilution and degradation during in vivo delivery
• The delivery system can achieve timing, positioning, fixed rate, and directional release in vivo, so that experimental animals can have a long-lasting effect after a single injection
• The system load is high, which can meet the delivery requirements of different doses
• Professional design and service team to provide you with reliable service and technical support
• Timely feedback technical report

CD BioSciences is focused on developing in vivo delivery systems using our core technologies. With our high-quality products and services, your delivery effect will be greatly improved. If you can't find the perfect in vivo delivery system, you can contact us. We can provide one-to-one personal customization services.

References

1. Chen J, et al.; Production and clinical development of nanoparticles for gene delivery. Mol Ther Methods Clin Dev. 2016, 3:16023.

* For research use only. Not for use in clinical diagnosis or treatment of humans or animals.